Effect of l-ornithine l-aspartate against thioacetamide-induced hepatic damage in rats

被引：20
|
作者：
Najmi, Abul K. [1 ]
Pillai, K. K. [1 ]
Pal, S. N. [3 ]
Akhtar, M. [1 ]
Aqil, M. [2 ]
Sharma, M. [1 ]
机构：
[1] Hamdard Univ, Dept Pharmacol, Fac Pharm, New Delhi 110062, India
[2] Hamdard Univ, Dept Pharmaceut, Fac Pharm, New Delhi 110062, India
[3] WHO, CH-1211 Geneva 27, Switzerland
来源：
INDIAN JOURNAL OF PHARMACOLOGY | 2010年 / 42卷 / 06期
关键词：
Hepatopathy; ornithine aspartate; oxidative stress; thioacetamide; DIETARY NUCLEOTIDES; ENCEPHALOPATHY; CIRRHOSIS; MANAGEMENT; EFFICACY; AMMONIA; ENZYMES;
D O I：
10.4103/0253-7613.71926
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Objective: To investigate the hepatoprotective activity of L-ornithine-L-aspartate against thioacetamide (TAA)-induced hepataopathy in rats. Materials and Methods: The hepatoprotective activity of L-ornithine-L-aspartate (OA) at a dose of 2 g/kg, p.o. for 10 days was evaluated against TAA (250 mg/kg, i.p. for 2 days) induced hepatopathy in rats. Biochemical parameters such as serum aspartate transaminase, alanine transaminase, alkaline phosphatase, bilirubin and glutathione, thiobarbituric acid reactive substances, and protein in liver tissues were estimated to assess the liver function. Results: TAA-induced pathogenic changes in the levels of the above indices were significantly (P < 0.01) reversed by the OA treatment. OA treatment also exhibited significant restoration of the hepatic architecture and lobular structure in histological evaluation of the rat liver sections. Conclusion: Ornithine aspartate exhibited significant hepatoprotective activity against TAA-induced hepatic damage in rats.
引用
收藏
页码：384 / 387
页数：4
相关论文
共 50 条
  • [1] L-Ornithine L-Aspartate In Acute Overt Hepatic Encephalopathy
    Sidhu, Sandeep S.
    Sharma, Barjesh C.
    Goyal, Omesh
    Kishore, Harsh
    Kaur, Navpreet
    HEPATOLOGY, 2017, 66 : 127A - 127A
  • [2] L-Ornithine L-Aspartate In Acute Overt Hepatic Encephalopathy
    Sidhu, Sandeep
    Sharma, Barjesh C.
    Goyal, Omesh
    Kishore, Harsh
    Kaur, Navpreet
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S546 - S546
  • [3] L-Ornithine L-aspartate in acute overt hepatic encephalopathy
    Sidhu, Sandeep Singh
    Sharma, Barjesh Chander
    Goyal, Omesh
    Kishore, Harsh
    Kaur, Navpreet
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 : 35 - 36
  • [4] L-ornithine L-aspartate in bouts of overt hepatic encephalopathy
    Sidhu, Sandeep Singh
    Sharma, Barjesh Chander
    Goyal, Omesh
    Kishore, Harsh
    Kaur, Navpreet
    HEPATOLOGY, 2018, 67 (02) : 700 - 710
  • [5] Minimal hepatic encephalopathy: Effect of rifaximin, probiotics and L-ornithine L-aspartate
    Sharma, Kapil
    Pant, Sanjay
    Dwivedi, Manisha
    Misra, S. P.
    Misra, Alok
    Narang, Sushil
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 : 275 - 276
  • [6] Effect of exogenous L-ornithine L-aspartate on ethanol induced testicular injury in Wistar rats
    Mailankot M.
    Jayalekshmi H.
    Chakrabarti A.
    Vasudevan D.M.
    Indian Journal of Clinical Biochemistry, 2009, 24 (1) : 94 - 97
  • [7] Clinical Efficacy of L-Ornithine–L-Aspartate in the Management of Hepatic Encephalopathy
    G. Kircheis
    M. Wettstein
    S. vom Dahl
    D. Häussinger
    Metabolic Brain Disease, 2002, 17 : 453 - 462
  • [8] PHARMACOLOGICAL STUDY ON L-ORNITHINE L-ASPARTATE
    SHIOYA, A
    TAMAMA, Y
    KURAISHI, K
    KAKIMOTO, M
    JAPANESE JOURNAL OF PHARMACOLOGY, 1964, 14 (02): : 201 - &
  • [9] L-Ornithine L-Aspartate is Effective and Safe for the Treatment of Hepatic Encephalopathy in Cirrhosis
    Sidhu, Sandeep S.
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2018, 8 (03) : 219 - 221
  • [10] Pharmacokinetic and Pharmacodynamic Properties of l-Ornithine l-Aspartate (LOLA) in Hepatic Encephalopathy
    Gerald Kircheis
    Stefan Lüth
    Drugs, 2019, 79 : 23 - 29
12345